Foged Camilla, Nielsen Hanne Moerck
Department of Pharmaceutics and Analytical Chemistry, University of Copenhagen, Faculty of Pharmaceutical Sciences, Universitetsparken 2, DK-2100 Copenhagen O, Denmark.
Expert Opin Drug Deliv. 2008 Jan;5(1):105-17. doi: 10.1517/17425247.5.1.105.
During the last decade, cell-penetrating peptides have been investigated for their ability to overcome the plasma membrane barrier of mammalian cells for the intracellular or transcellular delivery of cargoes as diverse as low molecular weight drugs, imaging agents, oligonucleotides, peptides, proteins and colloidal carriers such as liposomes and polymeric nanoparticles. Their ability to cross biological membranes in a non-disruptive way without apparent toxicity is highly desired for increasing drug bioavailability. This review provides an overview of the application of cell-penetrating peptides as transmembrane drug delivery agents, according to the recent literature, and discusses critical issues and future challenges in relation to fully understanding the fundamental principles of the cell-penetrating peptide-mediated membrane translocation of cargoes and the exploitation of their therapeutic potential.
在过去十年中,人们对细胞穿透肽进行了研究,考察其克服哺乳动物细胞质膜屏障的能力,以便将多种物质进行细胞内或跨细胞递送,这些物质包括低分子量药物、成像剂、寡核苷酸、肽、蛋白质以及脂质体和聚合物纳米颗粒等胶体载体。为提高药物生物利用度,人们迫切希望它们能够以无破坏的方式穿过生物膜且无明显毒性。根据最近的文献,本综述概述了细胞穿透肽作为跨膜药物递送剂的应用,并讨论了与充分理解细胞穿透肽介导的物质膜转运基本原理及其治疗潜力开发相关的关键问题和未来挑战。